UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

Blood, 2008-04, Vol.111 (7), p.3838-3848

2008

Link zum Volltext

Verfügbarkeit prüfen

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Oncotarget, 2015-09, Vol.6 (28), p.25109-25120

2015

Link zum Volltext

Verfügbarkeit prüfen

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Blood, 2004-11, Vol.104 (9), p.2879-2885

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5275: Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5275-5275

2015

Link zum Volltext

Verfügbarkeit prüfen

NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients

BMC cancer, 2013-06, Vol.13 (1), p.274-274, Article 274

2013

Link zum Volltext

Verfügbarkeit prüfen

Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Cancer research (Chicago, Ill.), 2015, Vol.75

2015

Link zum Volltext

Verfügbarkeit prüfen

IDH1 and IDH2 Mutations Are Frequent Genetic Alterations In Cytogenetically Normal Acute Myeloid Leukemia With Adverse Outcome

Blood, 2013-11, Vol.122 (21), p.3894-3894

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3518: TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3518-3518

2014

Link zum Volltext

Verfügbarkeit prüfen

TP53 mutations and MDM2SNP309 identify subgroups of AML patients with impaired outcome

European journal of haematology, 2015-04, Vol.94 (4), p.355-362

2015

Link zum Volltext

Verfügbarkeit prüfen

TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome

European journal of haematology, 2015-04, Vol.94 (4), p.355-362

2015

Link zum Volltext

Verfügbarkeit prüfen

TP 53 mutations and MDM2 SNP309 identify subgroups of AML patients with impaired outcome

European journal of haematology, 2015-04, Vol.94 (4), p.355-362

2015

Link zum Volltext

Verfügbarkeit prüfen

TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia

CANCER RESEARCH, 2014, Vol.74 (19)

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia

Biomarker research, 2014-10, Vol.2 (1), p.18-18, Article 18

2014

Link zum Volltext

Verfügbarkeit prüfen

MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia

European journal of haematology, 2010-09, Vol.85 (3), p.251-256

2010

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the isocitrate dehydrogenase 1/2 genes and IDH1 SNP 105C>T have a prognostic value in acute myeloid leukemia

Biomarker research, 2014, Vol.2 (18)

2014

Link zum Volltext

Verfügbarkeit prüfen

Anew perspective : molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

Blood, 2008, Vol.111 (7), p.3838-3848

2008

Link zum Volltext

Verfügbarkeit prüfen

Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome

Haematologica (Roma), 2005, Vol.90 (4), p.465

2005

Link zum Volltext

Verfügbarkeit prüfen

Absence of hot spot mutations of the PIK3CA gene in acute myeloid leukaemia

European journal of haematology, 2006-07, Vol.77 (1), p.86-87

2006

Link zum Volltext

Verfügbarkeit prüfen

4.23 MDM2 Promotor Polymorphism and Disease Characteristics in CLL: Individual Patient Data Meta-Analysis of 2598 CLL Patients

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S233-S235

2011

Link zum Volltext

Verfügbarkeit prüfen

Letter: Absence of hot spot mutations of the PIK3CA gene in acute myeloid leukaemia

European journal of haematology, 2006, Vol.77 (1), p.86

2006

Link zum Volltext

Verfügbarkeit prüfen

High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C

Proceedings of the National Academy of Sciences - PNAS, 2012-02, Vol.109 (7), p.2325-2329

2012

Link zum Volltext

Verfügbarkeit prüfen

The Brichos domain of prosurfactant protein C can hold and fold a transmembrane segment

Protein science, 2009-06, Vol.18 (6), p.1175-1182

2009

Link zum Volltext

Verfügbarkeit prüfen

A novel anti-amyloid chaperone

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, Vol.17, p.103

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)
Tagungsberichte
(2)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Humans
(10)
Life Sciences & Biomedicine
(10)
Medicin Och Hälsovetenskap
(9)
Adult
(7)
Hematology
(7)
Medicin
(7)
Medicine
(7)
Mutation
(7)
Prognostic Markers
(7)
Aged
(6)
Aged, 80 And Over
(6)
Female
(6)
Male
(6)
Middle Aged
(6)
Chronic Lymphocytic Leukemia
(4)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(4)
Oncology
(4)
Prognosis
(4)
Aml
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Abstract 5275: Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients

Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

IDH1 and IDH2 Mutations Are Frequent Genetic Alterations In Cytogenetically Normal Acute Myeloid Leukemia With Adverse Outcome

Abstract 3518: TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia

TP53 mutations and MDM2SNP309 identify subgroups of AML patients with impaired outcome

TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome

TP 53 mutations and MDM2 SNP309 identify subgroups of AML patients with impaired outcome

TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia

Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia

MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis

Mutations in the isocitrate dehydrogenase 1/2 genes and IDH1 SNP 105C>T have a prognostic value in acute myeloid leukemia

Anew perspective : molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome

Absence of hot spot mutations of the PIK3CA gene in acute myeloid leukaemia

4.23 MDM2 Promotor Polymorphism and Disease Characteristics in CLL: Individual Patient Data Meta-Analysis of 2598 CLL Patients

Letter: Absence of hot spot mutations of the PIK3CA gene in acute myeloid leukaemia

High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C

The Brichos domain of prosurfactant protein C can hold and fold a transmembrane segment

A novel anti-amyloid chaperone

Suchergebnisse filtern